Table of Contents
ISRN Urology
Volume 2012 (2012), Article ID 710734, 5 pages
http://dx.doi.org/10.5402/2012/710734
Clinical Study

Macroscopic Hematuria—A Leading Urological Problem in Patients on Anticoagulant Therapy: Is the Common Diagnostic Standard Still Advisable?

Department of Urology, Medical Centre of Postgraduate Education, Miedzylesie Hospital, 04-749 Warsaw, Poland

Received 29 November 2011; Accepted 18 January 2012

Academic Editors: A. M. El-Assmy and C. Magno

Copyright © 2012 Artur A. Antoniewicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hirsch, “Drug therapy: oral anticoagulant drugs,” The New England Journal of Medicine, vol. 324, pp. 1865–1875, 1991. View at Google Scholar
  2. A. J. Mariani, M. C. Mariani, C. Macchioni, U. K. Stams, A. Hariharan, and A. Moriera, “The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis,” Journal of Urology, vol. 141, no. 2, pp. 350–355, 1989. View at Google Scholar · View at Scopus
  3. C. S. Landefeld and R. J. Beyth, “Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention,” American Journal of Medicine, vol. 95, no. 3, pp. 315–328, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. C. D. Ritchie, E. A. Bevan, and J. Collier St. J., “Importance of occult haematuria found at screening,” British Medical Journal, vol. 292, no. 6521, pp. 681–683, 1986. View at Google Scholar · View at Scopus
  5. G. Palareti, N. Leali, S. Coccheri et al., “Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT),” The Lancet, vol. 348, no. 9025, pp. 423–428, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. J. T. Cuttino Jr, R. L. Clark, S. H. Feaster, and D. L. Zwicke, “The evaluation of gross hematuria in anticoagulated patients: efficacy of IV urography and cystoscopy,” American Journal of Roentgenology, vol. 149, no. 3, pp. 527–528, 1987. View at Google Scholar · View at Scopus
  7. S. J. Antolak Jr and G. T. Mellinger, “Urologic evaluation of hematuria occurring during anticoagulant therapy,” Journal of Urology, vol. 101, no. 1, pp. 111–113, 1969. View at Google Scholar · View at Scopus
  8. M. Barkin, W. Lopatin, S. Herschorn, and R. Comisarow, “Unexplained hematuria,” Canadian Journal of Surgery, vol. 26, no. 6, pp. 501–503, 1983. View at Google Scholar · View at Scopus
  9. U. Maier and M. Bergmann, “Hematuria under anticoagulant therapy as a symptom of urological diseases,” Urologe A, vol. 19, no. 3, pp. 165–166, 1980. View at Google Scholar · View at Scopus
  10. G. A. Schuster and G. A. Lewis, “Clinical significance of hematuria in patients on anticoagulant therapy,” Journal of Urology, vol. 137, no. 5, pp. 923–925, 1987. View at Google Scholar · View at Scopus
  11. J. G. van Savage, F. A. Fried, and E. Messing, “Anticoagulant associated hematuria: a prospective study,” Journal of Urology, vol. 153, no. 5, pp. 1594–1596, 1995. View at Google Scholar · View at Scopus
  12. D. H. Mosley, I. J. Schatz, G. M. Breneman, and J. W. Keyes, “Long-term anticoagulant therapy. Complications and control in a review of 978 cases,” Journal of the American Medical Association, vol. 186, pp. 914–916, 1963. View at Google Scholar
  13. J. Roos and H. E. van Joost, “The cause of bleeding during anticoagulant treatment,” Acta medica Scandinavica, vol. 178, no. 2, pp. 129–131, 1965. View at Google Scholar · View at Scopus
  14. A. J. Zweifler, W. W. Coon, and P. W. Willis, “Bleeding during oral anticoagulant therapy,” American Heart Journal, vol. 71, no. 1, pp. 118–123, 1966. View at Google Scholar · View at Scopus
  15. J. C. Blankenship, “Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors,” American Heart Journal, vol. 138, no. 4, pp. S287–S296, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Avidor, A. Nadu, and H. Matzkin, “Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment,” Urology, vol. 55, no. 1, pp. 22–24, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Lausen, R. Jensen, L. N. Jorgensen et al., “Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis,” European Journal of Surgery, vol. 164, no. 9, pp. 657–663, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. T. Nurmohamed, R. Verhaeghe, S. Haas et al., “A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery,” American Journal of Surgery, vol. 169, no. 6, pp. 567–571, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Koppenhagen, J. Adolf, and M. Matthes, “Low molecular weight heparin in postoerative thrombosis prophylaxis,” Wien Klin Wochenschr, vol. 82, pp. 349–353, 1994. View at Google Scholar
  20. R. S. McLeod, W. H. Geerts, K. W. Sniderman et al., “Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial,” Annals of Surgery, vol. 233, no. 3, pp. 438–444, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. P. Fricker, Y. Vergnes, R. Schach et al., “Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin®) in the prophylaxis of thromboembolic complications of abdominal oncological surgery,” European Journal of Clinical Investigation, vol. 18, no. 6, pp. 561–567, 1988. View at Google Scholar · View at Scopus
  22. S. Haas and C. W. Flosbach, “Prevention of postoperative thromboembolism with enoxaparin in general surgery: a German multicenter trial,” Seminars in Thrombosis and Hemostasis, vol. 19, supplement 1, pp. 164–173, 1993. View at Google Scholar
  23. A. Encke and K. Breddin, “Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery,” British Journal of Surgery, vol. 75, no. 11, pp. 1058–1063, 1988. View at Google Scholar
  24. J. A. Garcia-Vicente, J. Costa Pages, and P. Salva Lacombe, “Drug-induced hematuria,” Medicina Clinica, vol. 100, no. 3, pp. 110–114, 1993. View at Google Scholar · View at Scopus
  25. R. Bruyninckx, F. Buntinx, B. Aertgeerts, and V. Van Casteren, “The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice,” British Journal of General Practice, vol. 53, no. 486, pp. 31–35, 2003. View at Google Scholar · View at Scopus
  26. R. A. Cohen and R. S. Brown, “Clinical practice. Microscopic hematuria,” The New England Journal of Medicine, vol. 348, pp. 2330–2338, 2003. View at Google Scholar
  27. E. M. Messing, T. B. Young, V. B. Hunt et al., “Home screening for hematuria: results of a multi-clinic study,” Journal of Urology, vol. 148, no. 2, pp. 289–292, 1992. View at Google Scholar · View at Scopus
  28. M. H. Khadra, R. S. Pickard, M. Charlton, P. H. Powell, and D. E. Neal, “A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice,” Journal of Urology, vol. 163, no. 2, pp. 524–527, 2000. View at Google Scholar · View at Scopus
  29. P. L. Sanchez, M. H. Rubenstein, L. C. Harrell, P. J. Colon-Hernandez, J. K. Choo, and I. F. Palacios, “Frequency of gross hematuria shortly after percutaneous coronary intervention,” American Journal of Cardiology, vol. 88, no. 1, pp. 71–73, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. G. D. Grossfeld, M. S. Litwin, J. S. Wolf et al., “Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy–part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up,” Urology, vol. 57, no. 4, pp. 604–610, 2001. View at Google Scholar · View at Scopus
  31. C. Tomson and T. Porter, “Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence,” British Journal of Urology International, vol. 90, no. 3, pp. 185–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Kaufman and P. McLellan, “Urinary tract complications of anticoagulation therapy; ‘pseudotumour’ of the kidney,” British Journal of Radiology, vol. 41, no. 483, pp. 180–185, 1968. View at Google Scholar · View at Scopus
  33. R. L. Kroovand, T. E. Bell, and H. H. Kohler, “Coumadin induced hematuria simulating a renal pelvic tumor: case presentation and review of the literature,” Journal of Urology, vol. 111, no. 2, pp. 223–224, 1974. View at Google Scholar · View at Scopus
  34. W. W. Coon and P. W. Willis, “Hemorrhagic complications of anticoagulant therapy,” Archives of Internal Medicine, vol. 133, no. 3, pp. 386–392, 1974. View at Publisher · View at Google Scholar · View at Scopus